-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On May 7, Grand Pharmaceuticals (China) .
The Zhongda Hospital Affiliated to Southeast University, Tianjin Medical University Cancer Hospital, Hunan Provincial People's Hospital, and the First Affiliated Hospital of Xi'an Jiaotong University respectively implemented and successfully completed the precise interventional clinical operation of SIR-Spheres® Yttrium [90Y] Microsphere Injecti.
Previously, on January 30, the National Medical Products Administration (NMPA) approved the marketing application of SIR-Spheres® Yttrium [90Y] Microsphere Injection for unresectable colorectal cancer that has failed standard therapy Liver metastas.
The first batch of SIR-Spheres® yttrium [90Y] microsphere injection precision interventional surgery performed in four hospitals was performed by Professor Teng Gaojun, academician of the Chinese Academy of Sciences, president of Zhongda Hospital affiliated to Southeast University, and director of the interventional diagnosis and treatment center, Tianjin Medical Department Professor Lu Wei, Secretary of the Party Committee of University Cancer Hospital and Director of Liver Cancer Prevention and Research Center, Executive Vice President of Hunan Provincial People's Hospital, Professor Xiang Hua, Director of Clinical Interventional Medicine Research Center of Hunan Provincial People's Hospital, and Liu Qingguang, Vice President of the First Affiliated Hospital of Xi'an Jiaotong University Implemented by the team of professo.
Professor Teng Gaojun, director of the Interventional Diagnosis and Treatment Center of Zhongda Hospital Affiliated to Southeast University, said: "This internal radiation interventional treatment is the first batch of yttrium [90Y] microsphere injections after the approval of the State Food and Drug Administrati.
Academician of the Chinese Academy of Sciences, Professor Teng Gaojun of Zhongda Hospital Affiliated to Southeast University (the first from the right) led the team members to perform surgery on the patient
"Unlike traditional laparotomy, yttrium [90Y] microsphere injection is more like a precision-guided miniature nuclear bo.
Professor Lu Wei from Tianjin Medical University Cancer Hospital led the team members to perform treatment operations
The heads of the expert teams from the four hospitals said that the precise interventional surgery of SIR-Spheres® yttrium [90Y] microsphere injection currently carried out in the four hospitals was successf.
Professor Xiang Hua from Hunan Provincial People's Hospital led the interventional vascular surgery team to perform the operation
As the first radioactive microsphere product officially approved by the.
